Summary:
Double-Blind study to assess the efficacy and safety of topically applied DS107 cream versus vehicle cream to adults with mild to moderate Atopic Dermatitis
Qualified Participants Must:
• Have a confirmed diagnosis of active Atopic Dermatitis
•
Be at least 18 years of age
•
Have a minimum of 5% of the body affected
•
Be willing and able to stop current treatments for Atopic Dermatitis
Qualified Participants May Receive:
Complimentary study medication and appropriate physician related care